KPIs & Operating Metrics(New)

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Cost of Revenue EBIAT Gross Profit Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Oscar Health (OSCR) Long-Term Debt Issuances (2022)

Oscar Health's Long-Term Debt Issuances history spans 1 years, with the latest figure at $305.0 million for Q1 2022.

For Q1 2022, Long-Term Debt Issuances changed N/A year-over-year to $305.0 million; the TTM value through Dec 2022 reached $305.0 million, changed N/A, while the annual FY2025 figure was $410.0 million, N/A changed from the prior year.
Long-Term Debt Issuances reached $305.0 million in Q1 2022 per OSCR's latest filing.
In the past five years, Long-Term Debt Issuances ranged from a high of $305.0 million in Q1 2022 to a low of $305.0 million in Q1 2022.